444

TIANDA PHARMACEUTICALS LIMITED

No trades
See on Supercharts
Market capitalization
‪569.76 M‬HKD
−0.010HKD
‪−24.16 M‬HKD
‪532.09 M‬HKD
‪442.33 M‬
Beta (1Y)
0.40

About TIANDA PHARMACEUTICALS LIMITED

CEO
Wen Quan Fang
Headquarters
Hong Kong
Founded
1993
ISIN
KYG887471038
FIGI
BBG000BG6264
Tianda Pharmaceuticals Ltd. operates as an investment holding company, which engages in the research and development, manufacture and sale of pharmaceutical, biotechnology and healthcare products. It offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, detoxification drugs and complementary Healthcare Products. The company was founded in 1993 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 455 is 0.265 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange TIANDA PHARMACEUTICALS LIMITED stocks are traded under the ticker 455.
TIANDA PHARMACEUTICALS LIMITED is going to release the next earnings report on Jun 26, 2024. Keep track of upcoming events with our Earnings Calendar.
455 stock is 0% volatile and has beta coefficient of 0.40. Check out the list of the most volatile stocks — is TIANDA PHARMACEUTICALS LIMITED there?
Yes, you can track TIANDA PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
455 stock has risen by 1.92% compared to the previous week, the month change is a 5.36% fall, over the last year TIANDA PHARMACEUTICALS LIMITED has showed a 7.72% increase.
455 net income for the last quarter is ‪−20.03 M‬ HKD, while the quarter before that showed ‪−4.13 M‬ HKD of net income which accounts for −385.29% change. Track more TIANDA PHARMACEUTICALS LIMITED financial stats to get the full picture.
Today TIANDA PHARMACEUTICALS LIMITED has the market capitalization of ‪569.76 M‬, it has increased by 5.69% over the last week.
Yes, 455 dividends are paid annually. The last dividend per share was 0.00 HKD. As of today, Dividend Yield (TTM)% is 0%. Tracking TIANDA PHARMACEUTICALS LIMITED dividends might help you take more informed decisions.
Like other stocks, 455 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIANDA PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
455 reached its all-time high on Jun 1, 2007 with the price of 1.700 HKD, and its all-time low was 0.120 HKD and was reached on Jul 3, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIANDA PHARMACEUTICALS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIANDA PHARMACEUTICALS LIMITED stock shows the buy signal. See more of TIANDA PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.